Vivienne Williams, CEO of Cellix, is a specialist in microfluidic technologies with more than 18 years of experience in commercializing analytical and life-science tools. Cellix leads work package 6, point-of-care device optimization, and plays a key role in transforming CAR-T cell manufacturing by bringing therapy production directly to the point of care. With the Inish Analyzer, Cellix enables real-time quality control of patient T cells before infusion, ensuring their viability, concentration, and overall health.Collaboration. Innovation. Access. That’s what EASYGEN — and its partners like Cellix — stand for. #PointOfCare #CART #HealthcareTechnology #Microfluidics

‍